Copenhagen - Delayed Quote DKK
Genmab A/S (GMAB.CO)
At close: October 18 at 4:59 PM GMT+2
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
24.5
47th percentileEnvironmental Risk Score
1.1
Social Risk Score
16.3
Governance Risk Score
7.1
ESG Risk Score for Peers
Name | Total ESG Risk score | E | S | G |
---|---|---|---|---|
22UA.DU BIONTECH SE | 24 | -- | -- | -- |
TRML Tourmaline Bio, Inc. | 24 | -- | -- | -- |
GMAB.CO Genmab A/S | 24 | 1 | 16 | 7 |
IMRX Immuneering Corporation | 24 | -- | -- | -- |
NOVO-B.CO Novo Nordisk B A/S | 24 | 2 | 13 | 8 |
Controversy Level Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
ESG data provided by Sustainalytics, Inc. Last Updated on 9/2023
GMAB.CO
Category Average
1 Low Controversy Level
None 4 Severe
1.0 GMAB.CO
2.0 Category Average
Product Involvement Areas Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Products and Activities | Significant Involvement |
---|---|
Alcoholic Beverages | No |
Adult Entertainment | No |
Gambling | No |
Tobacco Products | No |
Animal Testing | Yes |
Fur and Specialty Leather | No |
Controversial Weapons | No |
Small Arms | No |
Catholic Values | Yes |
GMO | No |
Military Contracting | No |
Pesticides | No |
Thermal Coal | No |
Palm Oil | No |
Related Tickers
BAVA.CO Bavarian Nordic A/S
217.10
-1.54%
NOVO-B.CO Novo Nordisk A/S
807.20
-1.15%
ZEAL.CO Zealand Pharma A/S
804.00
+2.03%
GUBRA.CO Gubra A/S
428.00
-1.15%
ALK-B.CO ALK-Abelló A/S
172.50
-0.52%
BIOSGN.ST Biosergen AB
0.9860
+13.07%
HNSA.ST Hansa Biopharma AB (publ)
40.50
-1.89%
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
0.8960
+0.11%
EVAX Evaxion Biotech A/S
2.6400
-5.38%
FLUO.ST FluoGuide A/S
38.35
-0.90%